Dosimetry Group: Standard Uptake Value (SUV) Mean by Timepoint and Lesion Location
[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) · Source last updated 2020-10-23
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Measure
MEAN
Unit
Standard Uptake Value (SUV)
Interval / dispersion
Standard Deviation
Time frame
[68Ga]-NeoBOMB1 PET imaging acquired at Day 1 (0.15, 1.00, 2.00 and 4.00 hours)
What was measured
Targeting properties of \[68Ga\]-NeoBOMB1 were to be evaluated by semi-quantitatively assessing radiotracer uptake at lesion level, identified via PET Imaging. The SUVmean and SUVmax (g/mL) of each lesion were to be calculated and reported by lesion location with summary statistics at all imaging time points. SUV was to be calculated overall and split by GRPR positive and negative patients, as well as by tumor type. Only descriptive analysis performed.
Analysis population: Full Analysis Set (FAS). Dosimetry group targeted participants with Breast Cancer and Prostate Cancer, but only 2 participants from Breast Cancer arm enrolled in the Dosimetry Group. The results of the biopsied samples for all patients were positive for GRPR and thus the presentation of results according to GRPR expression were no longer suitable.
Groups in this outcome
Breast
All eligible participants were to receive recommended dose of \[68Ga\]-NeoBOMB1 of 3 Mega Becquerel (MBq)/Kg (+/- 10%) \[but not more than 250 and not less than 150 MBq. The maximum peptide mass administered was 50 microgram (µg)\].
Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.
Analysis denominator · Participants
Group
Source count
Breast
2
Reported measurements
SUV mean:Overall (0.15 hours)
Analysis denominator · Participants
Group
Source count
Breast
2
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
5.615
5.1265
Not reported
Not reported
Not reported
SUV mean:Nodal (0.15 hours)
Analysis denominator · Participants
Group
Source count
Breast
2
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
2.565
1.0394
Not reported
Not reported
Not reported
SUV mean:Skeletal (0.15 hours)
Analysis denominator · Participants
Group
Source count
Breast
2
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
2.140
0.2121
Not reported
Not reported
Not reported
SUV mean:Skin/Superficial (0.15 hours)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
1.250
NA
Not reported
Not reported
Only one participant analyzed
SUV mean:Soft Tissue/Visceral (0.15 hours)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
9.240
NA
Not reported
Not reported
Only one participant analyzed
SUV mean:Overall (1.00 hours)
Analysis denominator · Participants
Group
Source count
Breast
2
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
4.840
5.1336
Not reported
Not reported
Not reported
SUV mean:Nodal (1.00 hours)
Analysis denominator · Participants
Group
Source count
Breast
2
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
2.035
1.1667
Not reported
Not reported
Not reported
SUV mean:Skeletal (1.00 hours)
Analysis denominator · Participants
Group
Source count
Breast
2
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
1.935
1.2233
Not reported
Not reported
Not reported
SUV mean:Skin/Superficial (1.00 hours)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
1.520
NA
Not reported
Not reported
Only one participant analyzed
SUV mean:Soft Tissue/Visceral (1.00 hours)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
8.470
NA
Not reported
Not reported
Only one participant analyzed
SUV mean:Overall ( 2.00 hours)
Analysis denominator · Participants
Group
Source count
Breast
2
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
4.935
5.4659
Not reported
Not reported
Not reported
SUV mean:Nodal ( 2.00 hours)
Analysis denominator · Participants
Group
Source count
Breast
2
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
1.865
1.1667
Not reported
Not reported
Not reported
SUV mean:Skeletal ( 2.00 hours)
Analysis denominator · Participants
Group
Source count
Breast
2
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
1.635
0.7990
Not reported
Not reported
Not reported
SUV mean:Skin/Superficial ( 2.00 hours)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
1.650
NA
Not reported
Not reported
Only one participant analyzed
SUV mean:Soft Tissue/Visceral ( 2.00 hours)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
8.800
NA
Not reported
Not reported
Only one participant analyzed
SUV mean:Overall ( 4.00 hours)
Analysis denominator · Participants
Group
Source count
Breast
2
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
5.105
5.7064
Not reported
Not reported
Not reported
SUV mean:Nodal ( 4.00 hours)
Analysis denominator · Participants
Group
Source count
Breast
2
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
1.475
1.0819
Not reported
Not reported
Not reported
SUV mean:Skeletal ( 4.00 hours)
Analysis denominator · Participants
Group
Source count
Breast
2
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
1.930
1.2162
Not reported
Not reported
Not reported
SUV mean:Skin/Superficial ( 4.00 hours)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
1.100
NA
Not reported
Not reported
Only one participant analyzed
SUV mean:Soft Tissue/Visceral ( 4.00 hours)
Analysis denominator · Participants
Group
Source count
Breast
1
Values in Standard Uptake Value (SUV) · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Breast
9.140
NA
Not reported
Not reported
Only one participant analyzed
Complete source fields
classes
categories
measurements
group Id
OG000
spread
5.1265
value
5.615
denoms
counts
group Id
OG000
value
2
units
Participants
title
SUV mean:Overall (0.15 hours)
categories
measurements
group Id
OG000
spread
1.0394
value
2.565
denoms
counts
group Id
OG000
value
2
units
Participants
title
SUV mean:Nodal (0.15 hours)
categories
measurements
group Id
OG000
spread
0.2121
value
2.140
denoms
counts
group Id
OG000
value
2
units
Participants
title
SUV mean:Skeletal (0.15 hours)
categories
measurements
comment
Only one participant analyzed
group Id
OG000
spread
NA
value
1.250
denoms
counts
group Id
OG000
value
1
units
Participants
title
SUV mean:Skin/Superficial (0.15 hours)
categories
measurements
comment
Only one participant analyzed
group Id
OG000
spread
NA
value
9.240
denoms
counts
group Id
OG000
value
1
units
Participants
title
SUV mean:Soft Tissue/Visceral (0.15 hours)
categories
measurements
group Id
OG000
spread
5.1336
value
4.840
denoms
counts
group Id
OG000
value
2
units
Participants
title
SUV mean:Overall (1.00 hours)
categories
measurements
group Id
OG000
spread
1.1667
value
2.035
denoms
counts
group Id
OG000
value
2
units
Participants
title
SUV mean:Nodal (1.00 hours)
categories
measurements
group Id
OG000
spread
1.2233
value
1.935
denoms
counts
group Id
OG000
value
2
units
Participants
title
SUV mean:Skeletal (1.00 hours)
categories
measurements
comment
Only one participant analyzed
group Id
OG000
spread
NA
value
1.520
denoms
counts
group Id
OG000
value
1
units
Participants
title
SUV mean:Skin/Superficial (1.00 hours)
categories
measurements
comment
Only one participant analyzed
group Id
OG000
spread
NA
value
8.470
denoms
counts
group Id
OG000
value
1
units
Participants
title
SUV mean:Soft Tissue/Visceral (1.00 hours)
categories
measurements
group Id
OG000
spread
5.4659
value
4.935
denoms
counts
group Id
OG000
value
2
units
Participants
title
SUV mean:Overall ( 2.00 hours)
categories
measurements
group Id
OG000
spread
1.1667
value
1.865
denoms
counts
group Id
OG000
value
2
units
Participants
title
SUV mean:Nodal ( 2.00 hours)
denoms
counts
group Id
OG000
value
2
units
Participants
description
Targeting properties of \[68Ga\]-NeoBOMB1 were to be evaluated by semi-quantitatively assessing radiotracer uptake at lesion level, identified via PET Imaging. The SUVmean and SUVmax (g/mL) of each lesion were to be calculated and reported by lesion location with summary statistics at all imaging time points. SUV was to be calculated overall and split by GRPR positive and negative patients, as well as by tumor type. Only descriptive analysis performed.
dispersion Type
Standard Deviation
groups
description
All eligible participants were to receive recommended dose of \[68Ga\]-NeoBOMB1 of 3 Mega Becquerel (MBq)/Kg (+/- 10%) \[but not more than 250 and not less than 150 MBq. The maximum peptide mass administered was 50 microgram (µg)\].
id
OG000
title
Breast
param Type
MEAN
population Description
Full Analysis Set (FAS). Dosimetry group targeted participants with Breast Cancer and Prostate Cancer, but only 2 participants from Breast Cancer arm enrolled in the Dosimetry Group. The results of the biopsied samples for all patients were positive for GRPR and thus the presentation of results according to GRPR expression were no longer suitable.
reporting Status
POSTED
time Frame
[68Ga]-NeoBOMB1 PET imaging acquired at Day 1 (0.15, 1.00, 2.00 and 4.00 hours)
title
Dosimetry Group: Standard Uptake Value (SUV) Mean by Timepoint and Lesion Location